-
CSBTA Pharmacokinetics in MASH: Key Insights
2026-09-12
The 2025 Biomedicine & Pharmacotherapy study shows that MASH-associated pathology changes the systemic exposure, hepatic distribution, and hepatocyte accumulation of Corydalis saxicola Bunting total alkaloids and their major constituents. By integrating UHPLC-MS/MS, transporter, microsomal metabolism, and PXR-oriented experiments, the authors identify disease-dependent enzyme and transporter changes as plausible sources of pharmacokinetic variability and dosing risk.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-09-11
Masitinib (AB1010) is a DMSO-compatible, selective tyrosine kinase inhibitor for cancer research involving KIT, PDGFRα, PDGFRβ, selected KIT-mutant models, and mast cell responses. This guide explains how to prepare and quality-control the compound while defining its limits: it is insoluble in water and ethanol and is not a substitute for clinically validated gastrointestinal stromal tumor treatment.
-
ARCA EGFP mRNA: A Smarter Transfection Control
2026-09-11
ARCA EGFP mRNA is more than a fluorescent marker: it is a practical tool for separating delivery, translation, and cell-specific expression effects. This guide explains how to use the reporter to interpret fluorescence-based transfection assays and optimize emerging lipid nanoparticle systems.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-10
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) provides an affinity-purified rabbit IgG for detecting human, mouse, and rat HMGB1 in Western blot, frozen or paraffin immunohistochemistry, and flow cytometry. This no-paper-mode guide is based on the product dossier and practical QC controls; the reagent is for research use only and is not diagnostic, therapeutic, or clinically validated.
-
GM 6001: From MMP Biology to Translation
2026-09-10
GM 6001 (Galardin) offers translational researchers a practical way to test whether matrix metalloproteinase-driven extracellular matrix remodeling is causal in disease phenotypes. This article connects perineuronal-net preservation in Alzheimer’s disease models with assay strategy, meniscal healing research, EGFR transactivation inhibition, cancer cell proliferation modulation, and vascular smooth muscle cell migration inhibition—while defining the limits of broad-spectrum pharmacology.
-
Ruxolitinib Workflows for JAK-STAT Research
2026-09-09
Build reproducible Ruxolitinib assays that connect biochemical JAK1/JAK2 inhibition with phospho-signaling, progenitor growth, and immune-cell readouts. This workflow also adapts a neonatal monocyte inflammation model while clearly separating TLR4-proximal effects from downstream JAK-STAT signaling.
-
Trelagliptin, RUNX2, and Osteoblast Differentiation
2026-09-09
The reference study identifies an osteogenic activity of trelagliptin in MC3T3-E1 cells, linking enhanced mineralization and osteoblast-marker expression to RUNX2 and AMPK signaling. Its findings extend investigation of this long-acting DPP-4 inhibitor beyond glycemic biology while remaining limited to an in vitro model that requires validation in primary cells and osteoporosis models.
-
Imipramine: A Translational Autophagy Strategy
2026-09-08
Imipramine can serve as a research bridge between transporter pharmacology, autophagy, apoptosis, and lipid metabolism. This thought-leadership article translates ceramide-centered virology findings into bounded, mechanism-focused workflows for glioma, leukemia, neuroscience, and immunology research.
-
Tiamulin (Thiamutilin): From Ribosome to Translation
2026-09-08
Tiamulin is more than a veterinary pleuromutilin antibiotic: it is a mechanistically distinctive tool for connecting bacterial translation, inflammatory signaling, pharmacokinetics, and residue science. This thought-leadership guide shows how translational researchers can use Tiamulin (Thiamutilin) to design stronger infection and inflammation studies while accounting for species-specific metabolism, exposure, formulation, and the limits of cross-domain interpretation.
-
Computational Hapten Design for Dual Toxin Detection
2026-09-07
Li and colleagues developed a computationally guided hapten-selection strategy to generate monoclonal antibodies that recognize multiple amatoxins or phallotoxins with more uniform sensitivity. The resulting dual-target fluorescent immunochromatographic assay detected both toxin groups in mushroom matrices at low microgram-per-kilogram levels, offering a rapid screening complement to laboratory instrumental analysis.
-
ONX-0914 (PR-957) for Immunoproteasome Assays
2026-09-05
Use ONX-0914 (PR-957) to separate LMP7-dependent immune signaling from broad proteasome effects in cytokine and autoimmune-model workflows. This guide combines concentration-response design, PBMC assay controls, and a neuroscience-inspired strategy for distinguishing primary pathway effects from downstream cellular changes.
-
BV6: A Causal Map of IAP-Driven Cell Death
2026-09-05
Explore BV6 as an IAP antagonist through a causal, assay-focused framework linking target engagement, apoptosis induction, lysosomal membrane permeabilization, and combination responses. This guide also clarifies how to design interpretable studies in lung cancer, immune-cell models, and endometriosis research.
-
M344 Histone Deacetylase Inhibitor Workflows
2026-09-04
M344 is a cell-permeable histone deacetylase inhibitor for connecting chromatin remodeling with proliferation arrest, apoptosis, differentiation, migration, and treatment-response assays. This guide translates published neuroblastoma findings into practical workflows while addressing dosing, solubility, controls, and endpoint selection across cancer and viral-latency models.
-
Influenza Hemagglutinin (HA) Peptide Workflow
2026-09-04
Build cleaner native elution and protein-interaction workflows around the Influenza Hemagglutinin (HA) Peptide, from Anti-HA capture through assay-ready recovery. Practical parameters, controls, and troubleshooting help distinguish poor expression, inaccessible tags, antibody carryover, and incomplete competitive release.
-
Acacetin–MAPK1/HMOX1 Axis in Disc Degeneration
2026-09-03
This study identifies an acacetin-mediated MAPK1/HMOX1 pathway through which Duhuo Jisheng decoction may protect nucleus pulposus cells from pyroptosis during intervertebral disc degeneration. By integrating chemical profiling, mitochondrial assays, target analysis, and rat validation, the work connects mitophagy enhancement with suppression of inflammatory cell death.